Recombinant anti- human ErbB2/HER2 Antibody (Trastuzumab), Clone: [ABM2A1G1], Monoclonal

Produktübersicht

• Artikelname: Recombinant anti- human ErbB2/HER2 Antibody (Trastuzumab), Clone: [ABM2A1G1], Monoclonal
• Artikelnummer: ABI-10-2002-500
• Hersteller Artikelnummer: 10-2002-500
• Alternativnummer: ABI-10-2002-500-500UG
• Hersteller: Abeomics
• Kategorie: Antikörper
• Applikation: FA, FACS
• Spezies Reaktivität: Human
• Alternative Synonym: ERBB2|| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2|| CD340|| HER 2|| HER2|| NEU|| herstatin|| p185erbB2|| proto-oncogene Neu|| c-erb B2/neu protein|| proto-oncogene c-ErbB-2.

Produktbeschreibung

Target: ErbB2 Trade name: Samceptin Generic name: Trastuzumab Product Origin: Recombinant in CHO cells Product Construction: Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 g1- chain), disulfide with human-mouse monoc

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [ABM2A1G1]
• NCBI: 2064
• UniProt: P04626
• Reinheit: Purity: >98.0% as determined by SEC-HPLC & SDS-PAGE.
• Formulierung: Purified
• Target-Kategorie: Receptor tyrosine-protein kinase erbB-2

Anwendungsbeschreibung

• Application Verdünnung: The biological activities of Samcepetin was compared with commercially available innovator drug, Herceptin from Roche. Recommended dilutions: FACS: 1-2µg/10 6 cells, ADCC: 20-25 mg/ml. However, this need to be optimized based on the research applications